Abbott?s Ross Division has voluntarily issued a nationwide recall for one lot of alilmentum, two lots of Similac Advance Liquid Infant Formula Ready-to-Feed 32-oz. plastic bottles, and one lot of hospital discharge kits.
Abbott?s Ross Division has voluntarily issued a nationwide recall for one lot of alilmentum, two lots of Similac Advance Liquid Infant Formula Ready-to-Feed 32-oz. plastic bottles, and one lot of hospital discharge kits. The following lots are being recalled: One lot of Similac Alimentum Advance liquid ready-to-eat infant formula (Stock Code #57512, Lot #401895V, ?use-by 1 May 2007? printed on the back of the bottle); two lots of Similac Advance with Iron Liquid Ready-to-Feed Infant Formula (Stock Code #55961, Lots #40177RH and #40172RH, ?use-by 1 November 2007? printed on the back of the bottle); additionally, one lot of Similac Advance Hospital Discharge Kits may have included some of the affected 32-oz. plastic bottles. The lot number for these discharge kits (Stock Code #58986, Lot #41699D5) can be found on the back of the bear tag attached to the kit. Abbott is initiating this recall because some bottles from these lots may not contain as much vitamin C as indicated on the label. For more information, visit www.abbott.com.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA Approves Lebrikizumab-lbkz for Moderate-to-Severe Atopic Dermatitis
September 16th 2024Lebrikizumab-lbks is a targeted treatment that addresses the root cause of atopic dermatitis; by reducing inflammation throughout the body, it can help alleviate the dry, itchy, and irritated skin that often characterizes the condition.